News
2024-02-20
Dr. Jonathan Levenson joins Cellectricon’s advisory board
Cellectricon has appointed Dr. Jonathan Levenson, Chief Scientific Officer at FireCyte Therapeutics, to its Scientific Advisory Board. Dr. Levenson brings...
News
2024-02-15
Cellectricon’s expertise in pain research recognized by second EU research grant
MÖLNDAL, SWEDEN Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has received follow-on funding for bone pain research...
Events
March 5-9, 2024
AD/PD 2024
The AD/PD 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders takes place in Lisbon, Portugal on...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Events
February 8, 2024
Webcast - Tools for discovery of novel targets and molecules involved in neuroplasticity
Webcast Description: The incidence of neuropsychiatric disorders has increased dramatically over the past decades, necessitating continued efforts to identify drugs...
News
2024-02-05
Senior Scientist, high content imaging and analysis
Cellectricon is an innovative discovery services provider with a focus on the neurobiology of peripheral and central nervous system diseases....
News
2024-01-03
New publication: A Microfluidic High-Capacity Screening Platform for Neurological Disorders
We are happy to announce the publication of “A Microfluidic High-Capacity Screening Platform for Neurological Disorders”. In the paper, published...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

News
2023-11-28
Cellectricon is looking for a scientist to join our team
Cellectricon is an innovative services provider dedicated to advancing drug discovery and research in the areas of peripheral neuropathies, neuroplasticity...
Events
November 11-15, 2023
Neuroscience 2023
The Neuroscience 2023 meeeting takes place in Washington D.C. on November 11-15. During the conference, we will present several posters...
News
2023-10-19
Cellectricon receives CIR (French Research Tax Credit) accreditation
MÖLNDAL, SWEDEN Cellectricon AB, a services provider dedicated to advancing neuroscience drug discovery, today announced that it has received CIR...